Vaccine-maker’s Ottawa R&D efforts get boost thanks to millions in fresh funding
VBI Vaccines will immediately have access to up to $50 million (all terms U.S.) in cash, consisting of $30 million in refinanced funding as well
Skip to content
Variation Biotechnologies
Ottawa consultant warns of ‘venture capital Ice Age’ as funding dries up in Q3
In Ottawa, 24 companies have landed a combined $91 million in VC funding from January to the end of September, according to the latest Canadian
Ottawa biotech lab gets $56M shot in the arm for COVID vaccine research
Variation Biotechnologies is working with the National Research Council to create a vaccine that would target the novel coronavirus as well as other deadly viruses.
Get our email updates
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.
The Latest
Video
OBJ360
Sponsored
Sponsored
Campaign to Create Tomorrow
Learn more about The Ottawa Hospital's $500-million fundraising campaign, the largest in our city’s history, which will transform the future of healthcare in Ottawa.
EXPERT BLOGS
Business advisory committee: Giving a voice to the ByWard Market businesses
ByWard Market District Authority
EVENTS
OBJ news delivered to your inbox
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.